Kings Path Partners LLC Purchases New Stake in Phibro Animal Health Co. (NASDAQ:PAHC)

Kings Path Partners LLC acquired a new position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,000 shares of the company's stock, valued at approximately $235,000.

Other hedge funds have also modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. bought a new position in Phibro Animal Health in the fourth quarter valued at approximately $29,000. Lazard Asset Management LLC raised its holdings in Phibro Animal Health by 2,739.7% in the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after purchasing an additional 1,589 shares during the period. Aquatic Capital Management LLC acquired a new stake in Phibro Animal Health in the fourth quarter worth $69,000. Virtus Fund Advisers LLC acquired a new stake in Phibro Animal Health in the fourth quarter worth $69,000. Finally, Quantbot Technologies LP raised its holdings in shares of Phibro Animal Health by 65.1% during the fourth quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock worth $107,000 after acquiring an additional 2,018 shares during the period. 99.34% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on PAHC. Morgan Stanley increased their price target on Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 8th. Wall Street Zen upgraded Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Finally, Barclays increased their price target on Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a report on Monday, February 10th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $20.00.

Phibro Animal Health Price Performance

PAHC stock traded down $0.18 during mid-day trading on Tuesday, hitting $24.40. The company had a trading volume of 81,883 shares, compared to its average volume of 201,845. The company has a market capitalization of $989.03 million, a price-to-earnings ratio of 50.83, a P/E/G ratio of 0.45 and a beta of 0.62. Phibro Animal Health Co. has a 12-month low of $16.16 and a 12-month high of $26.55. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The company has a 50-day moving average price of $20.58 and a 200 day moving average price of $21.85.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. The business had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, research analysts anticipate that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.97%. The ex-dividend date of this dividend is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio (DPR) is 61.54%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.